Horizon Pharma plc buy BiotechBee
Start price
07.09.22
/
70%
€61.22
Target price
31.12.25
€100.00
Performance (%)
73.41%
End price
14.12.22
€106.16
Summary
This prediction ended on 14.12.22 with a price of €106.16. With a performance of 73.41% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Horizon Pharma plc | - | - | - | - |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % | 60,42 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % | 87,82 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % | 66,93 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % | 60,46 % |
According to BiotechBee what are the pros and cons of Horizon Pharma plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Horizon Pharma plc diskutieren
Buy mit Kursziel 100,0